advertisement

---

Sakata R 14

Showing records 1 to 14 | Display all abstracts from Sakata R

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Sakata R
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Zhang X; Guo PY
Ophthalmology 2023; 130: 111-119

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Fujishiro T; Saito H
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Lin C
Ophthalmology 2023; 130: 111-119

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Nakamura N
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Li F
Ophthalmology 2023; 130: 111-119

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Honjo M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Nguyen A
Ophthalmology 2023; 130: 111-119

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Shirato S
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Sakata R; Higashita R
Ophthalmology 2023; 130: 111-119

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Miyamoto E; Yamada Y
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Okamoto K; Yu M
Ophthalmology 2023; 130: 111-119

---

106238 Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 63-69

---

106850 Assessment of Iris Trabecular Contact in Eyes with Gonioscopic Angle-Closure
Aihara M; Aung T; Lin S; Leung CK
Ophthalmology 2023; 130: 111-119

---